Evidence map›Paper›PMID 26686880›Full record

ArticleNature communications2015

Rapid antibiotic-resistance predictions from genome sequence data for Staphylococcus aureus and Mycobacterium tuberculosis.

Phelim Bradley, N Claire Gordon, Timothy M Walker, Laura Dunn, Simon Heys, Bill Huang, Sarah Earle, Louise J Pankhurst, Luke Anson, Mariateresa de Cesare and 18 more

Erratum issuedAbstract read
In one paragraph

Article in Nature communications, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 287 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
287citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

287 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Open-access genomic drug resistance prediction tools forJournal of clinical microbiology · 2026
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Prediction of antimicrobial resistance inMicrobiology spectrum · 2025
    Article

227 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

28 authors.

Phelim BradleyWellcome Trust Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK.ORCID http://orcid.org/0000-0003-3967-3037
N Claire GordonNuffield Department of Medicine, University of Oxford, Oxford OX1 1NF, UK.
Timothy M WalkerNuffield Department of Medicine, University of Oxford, Oxford OX1 1NF, UK.
Laura DunnNuffield Department of Medicine, University of Oxford, Oxford OX1 1NF, UK.
Simon HeysWellcome Trust Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK.
Bill HuangWellcome Trust Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK.
Sarah EarleNuffield Department of Medicine, University of Oxford, Oxford OX1 1NF, UK.
Louise J PankhurstNuffield Department of Medicine, University of Oxford, Oxford OX1 1NF, UK.
Luke AnsonNuffield Department of Medicine, University of Oxford, Oxford OX1 1NF, UK.
Mariateresa de CesareWellcome Trust Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK.
Paolo PiazzaWellcome Trust Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK.
Antonina A VotintsevaNuffield Department of Medicine, University of Oxford, Oxford OX1 1NF, UK.
Tanya GolubchikNuffield Department of Medicine, University of Oxford, Oxford OX1 1NF, UK.
Daniel J WilsonWellcome Trust Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK.
David H WyllieNuffield Department of Medicine, University of Oxford, Oxford OX1 1NF, UK.
Roland DielInstitute for Epidemiology, University Medical Hospital Schleswig-Holstein, Niemannsweg 11, 24105 Kiel, Germany.
Stefan NiemannMolecular and Experimental Mycobacteriology, Research Centre Borstel, Parkallee 1, 23845 Borstel, Germany.
Silke FeuerriegelMolecular and Experimental Mycobacteriology, Research Centre Borstel, Parkallee 1, 23845 Borstel, Germany.
Thomas A KohlMolecular and Experimental Mycobacteriology, Research Centre Borstel, Parkallee 1, 23845 Borstel, Germany.
Nazir IsmailCentre for Tuberculosis, National Institute for Communicable Diseases, Private Bag X4 Sandringham, Johannesburg 2131, South Africa.
Shaheed V OmarCentre for Tuberculosis, National Institute for Communicable Diseases, Private Bag X4 Sandringham, Johannesburg 2131, South Africa.
E Grace SmithRegional Centre for Mycobacteriology, PHE Public Health Laboratory Birmingham. Heartlands Hospital, Bordesley Green East, Birmingham B9 5SS, UK.
David BuckWellcome Trust Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK.
Gil McVeanWellcome Trust Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK.
A Sarah WalkerNuffield Department of Medicine, University of Oxford, Oxford OX1 1NF, UK.
Tim E A PetoNuffield Department of Medicine, University of Oxford, Oxford OX1 1NF, UK.
Derrick W CrookNuffield Department of Medicine, University of Oxford, Oxford OX1 1NF, UK.
Zamin IqbalWellcome Trust Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK.ORCID http://orcid.org/0000-0001-8466-7547

Funding

Medical Research Council G0800778Medical Research Council MR/J011398/1Medical Research Council MR/K023985/1Wellcome Trust 087646/Z/08/ZWellcome Trust 090532/Z/09/ZWellcome Trust 100956Wellcome Trust 100956/Z/13/ZWellcome Trust 101237Wellcome Trust 101237/Z/13/ZWellcome Trust 102541Wellcome Trust 102541/Z/13/Z
6 · The paper itself

Abstract

The rise of antibiotic-resistant bacteria has led to an urgent need for rapid detection of drug resistance in clinical samples, and improvements in global surveillance. Here we show how de Bruijn graph representation of bacterial diversity can be used to identify species and resistance profiles of clinical isolates. We implement this method for Staphylococcus aureus and Mycobacterium tuberculosis in a software package ('Mykrobe predictor') that takes raw sequence data as input, and generates a clinician-friendly report within 3 minutes on a laptop. For S. aureus, the error rates of our method are comparable to gold-standard phenotypic methods, with sensitivity/specificity of 99.1%/99.6% across 12 antibiotics (using an independent validation set, n=470). For M. tuberculosis, our method predicts resistance with sensitivity/specificity of 82.6%/98.5% (independent validation set, n=1,609); sensitivity is lower here, probably because of limited understanding of the underlying genetic mechanisms. We give evidence that minor alleles improve detection of extremely drug-resistant strains, and demonstrate feasibility of the use of emerging single-molecule nanopore sequencing techniques for these purposes.

Indexed as

Drug Resistance, Multiple, BacterialGenome, BacterialAnti-Bacterial AgentsHumansMicrobial Sensitivity TestsMycobacterium tuberculosisStaphylococcal InfectionsStaphylococcus aureusTuberculosisAnti-Bacterial Agents

Identifiers

PMID26686880
PMCPMC4703848

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.